SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Opto Circuits trades jubilantly on receiving USFDA nod to market New Powerheart G5 AED

06 May 2015 Evaluate

Opto Circuits (India) is currently trading at Rs. 22.00, up by 2.30 points or 11.68% from its previous closing of Rs. 19.70 on the BSE.

The scrip opened at Rs. 19.60 and has touched a high and low of Rs. 22.50 and Rs. 19.60 respectively. So far 551712 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 44.50 on 22-May-2014 and a 52 week low of Rs. 18.00 on 22-Oct-2014.

Last one week high and low of the scrip stood at Rs. 22.50 and Rs. 19.05 respectively. The current market cap of the company is Rs. 477.37 crore.

The promoters holding in the company stood at 28.24% while Institutions and Non-Institutions held 17.70% and 54.06% respectively.

Opto Circuits (India)’s group company - Cardiac Science Corporation’s Powerheart G5 AED with CRPD has received 510(k) market clearance from the US FDA (Food and Drug Administration), allowing the company to begin selling the AED with CPRD along with its successful Powerheart G3 and G5 product line. The Powerheart family of AEDs is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest (SCA).

Cardiac Science has been working to reduce SCA fatalities since it introduced the first fully automated external defibrillator. The Powerheart G5 with CPRD will be available for purchase in the United States later this year.

Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×